OneMedNet Corp 8-K, filed Dec 20, 2024
OneMedNet Corp (ONMD)
About this 8-K
OneMedNet Corp filed this 8-K on December 20, 2024, reporting on events of December 19, 2024.
Items reported
- Item 5.07: Shareholder vote results
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code:
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On December 19, 2024, OneMedNet Corporation (the “Company”) held its 2024 Annual Meeting of Stockholders as a virtual meeting online via live audio webcast (the “Annual Meeting”). There were 27,987,427 shares of common stock entitled to be voted at the Annual Meeting, of which 23,320,278 shares were voted in person or by proxy. The results of each item voted at the Annual Meeting are set forth below.
Proposal 1. Election of Class I Directors. The stockholders elected the following three Class I directors to hold office until the Company’s 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The voting results were as follows:
| Director | For | Withhold | Broker Non-Votes | |||
| Eric Casaburi | 20,913,825 | 76,904 | 2,329,549 | |||
| Aaron Green | 20,979,581 | 11,148 | 2,329,549 | |||
| Dr. Thomas Kosasa | 20,957,245 | 33,484 | 2,329,549 |
Proposal 2. Ratification of Appointment of Withum Smith+Brown, PC as Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Withum Smith+Brown, PC as the Company’s independent registered public accounting firm for the year ending December 31, 2024. The voting results were as follows:
| For | Against | Abstain | ||
| 23,286,649 | 28,172 | 5,457 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: December 20, 2024
| ONEMEDNET CORPORATION | ||
| By: | /s/ Aaron Green | |
| Aaron Green | ||
| Chief Executive Officer | ||